Arya Subhash C, Agarwal Nirmala
Vaccine. 2006 Jun 12;24(24):5108-9. doi: 10.1016/j.vaccine.2006.04.009. Epub 2006 May 5.
Investigations to assess episodes of any natural Japanese encephalitis (JE) infection following prior immunizations with JE inactivated vaccine in Japan are commendable. Employing differential production of nonstructural 1 protein NS1, during a natural infection and not by inactivated JE vaccine [Konishi E, Shoda M, Yamamoto S, Arai S, Tanaka-Taya K, Okabe N. Natural infection with Japanese encephalitis virus among inhabitants of Japan: a nationwide survey of antibodies against nonstructural 1 protein. Vaccine 2006;24:3054-956], natural infection was manifest in eight selected prefectures in Japan. Moreover, it would be possible to detect any foreign pathogenic JE virus (JEV) or any native strains associated with any major shift in JE clinical presentations. On the opposite, any NS1 antibody screen might be invalid among recipients of live JE vaccines.
在日本,对既往接种过日本脑炎(JE)灭活疫苗后发生的任何自然JE感染病例进行调查,这值得称赞。利用自然感染而非灭活JE疫苗产生的非结构1蛋白NS1的差异表达[小西英、庄田真、山本幸、新井史、田中田矢香、冈部直。日本居民中日本脑炎病毒的自然感染:一项针对非结构1蛋白抗体的全国性调查。《疫苗》2006年;24:3054 - 956],在日本八个选定的县发现了自然感染。此外,有可能检测到任何外来致病性JE病毒(JEV)或与JE临床表现的任何重大变化相关的任何本土毒株。相反,对于接种活JE疫苗的人群,任何NS1抗体筛查可能无效。